Celcuity Inc.（CELC）價格預測CELCCelcuity Inc.

Alphio's CELC stock price prediction model matches the current Celcuity Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $65.96 (+0.25%). The 1-week path is $67.38 (+2.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Celcuity Inc is a good buy right now due to its recent FDA approval of the cancer treatment Revtorpyk, which has a significant market potential given that HR+/HER2 breast cancer accounts for approximately 70% of over two million diagnosed cases globally. The current price is $65.25, and analysts have set price targets ranging from $140 to $178, indicating substantial upside potential. The RSI is at 57.197, suggesting that the stock is neither overbought nor oversold, which is favorable for entry. However, the main risk is the company's negative earnings trend, with a reported EPS of -1.44, which reflects ongoing financial challenges that could impact future performance.

Celcuity Inc. (CELC) last closed at $65.8000031, gaining +0.84%. These facts feed the 1-day and 1-week CELC price prediction above.